eOD-GT8 60mer based vaccine (TSRI/IAVI/The Rockefeller University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameeOD-GT8 60mer based vaccine (TSRI/IAVI/The Rockefeller University)
Drug Alias NameeOD-GT8 60mer based vaccine (TSRI/IAVI/Rockefeller)immunogen based vaccine (TSRI/IAVI/Rockefeller University)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionB-lymphocyte stimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInternational Aids Vaccine Initiative
China Registration ClassN/A

Develop Information

Active CompaniesInternational Aids Vaccine InitiativeThe Scripps Research Institute IncThe Rockefeller University
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A